4.6 Review

Macrophages and neutrophils in SLE-An online molecular catalog

期刊

AUTOIMMUNITY REVIEWS
卷 11, 期 5, 页码 365-372

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.autrev.2011.10.010

关键词

Myeloid cells; Autoimmunity; Innate immunity; Inflammation; Lupus

向作者/读者索取更多资源

Systemic Lupus Erythematosus (SLE) is a heterogeneous group of autoimmune disorders defined by a consensus of clinical and laboratory criteria. Much of the pathophysiology and therapy of SLE has focused on autoimmune B and T cells of the adaptive immune system. Recently, focus has shifted to the role of myeloid cells like neutrophils and macrophages part of the innate immune system in SLE pathogenesis. These cells have altered molecular profiles affecting multiple pathways, but no salient overview has been undertaken to broadly define and categorize this dysregualtion. Here we endeavor to provide this overview and build a new freely accessible online resource for this purpose (http://www.mohanlab.org/SLE_BASE/myeloid_cells/). Published by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE

Jacob J. Orme, Yong Du, Kamala Vanarsa, Jessica Mayeux, Li Li, Azza Mutwally, Cristina Arriens, Soyoun Min, Jack Hutcheson, Laurie S. Davis, Benjamin F. Chong, Anne B. Satterthwaite, Tianfu Wu, Chandra Mohan

CLINICAL IMMUNOLOGY (2016)

Article Immunology

Intra-articular nuclear factor-B blockade ameliorates collagen-induced arthritis in mice by eliciting regulatory T cells and macrophages

S-Y. Min, M. Yan, Y. Du, T. Wu, E. Khobahy, S-R. Kwon, V. Taneja, A. Bashmakov, S. Nukala, Y. Ye, J. Orme, D. Sajitharan, H-Y. Kim, C. Mohan

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)

Editorial Material Medicine, General & Internal

59-Year-Old Man With Fatigue, Weight Loss, and Hepatomegaly

Jacob J. Orme, Surbhi Sidana, Wilson I. Gonsalves

MAYO CLINIC PROCEEDINGS (2018)

Article Multidisciplinary Sciences

Leukocyte Beta-Catenin Expression Is Disturbed in Systemic Lupus Erythematosus

Jacob J. Orme, Yong Du, Kamala Vanarsa, Tianfu Wu, Anne B. Satterthwaite, Chandra Mohan

PLOS ONE (2016)

Editorial Material Oncology

Microenvironment-Mediated Resistance to Anti-Androgen Therapy

Jacob J. Orme, Haojie Huang

CANCER CELL (2020)

Article Oncology

Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles

Jacob J. Orme, Elizabeth Ann L. Enninga, Fabrice Lucien-Matteoni, Heather Dale, Edwin Burgstaler, Susan M. Harrington, Matthew K. Ball, Aaron S. Mansfield, Sean S. Park, Mathew S. Block, Svetomir N. Markovic, Yiyi Yan, Haidong Dong, Roxana S. Dronca, Jeffrey L. Winters

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Article Medicine, General & Internal

Expression of ADAM Proteases in Bladder Cancer Patients with BCG Failure: A Pilot Study

Renate Pichler, Andrea Katharina Lindner, Georg Schaefer, Gennadi Tulchiner, Nina Staudacher, Martin Mayr, Eva Comperat, Jacob J. Orme, Gert Schachtner, Martin Thurnher

Summary: Despite the low expression of PD-L1 in both tumor regions and cell types, high expression of ADAM17 was found in RC specimens obtained after BCG failure. Additionally, increased expression of GATA3, IL-10, and IL-10R suggested an immunosuppressive tumor microenvironment in BCG failure patients. This study highlights the potential role of ADAM proteases in cleaving PD-L1 from bladder tumor cells and immune cells in BCG failure cases, indicating the necessity of supplementing PD-L1 assessment with ADAM10/17.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Medicine, General & Internal

HUS1 as a Potential Therapeutic Target in Urothelial Cancer

Andrea Katharina Lindner, Tobias Furlan, Jacob J. Orme, Gennadi Tulchiner, Nina Staudacher, David D'Andrea, Zoran Culig, Renate Pichler

Summary: HUS1 may act as an oncogene in urothelial cancer and might be a key determinant of the cellular response to cisplatin-based chemotherapy.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Oncology

ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance

Jacob J. Orme, Khalid A. Jazieh, Tiancheng Xie, Susan Harrington, Xin Liu, Matthew Ball, Benjamin Madden, M. Cristine Charlesworth, Tariq U. Azam, Fabrice Lucien, Bharath Wootla, Yanli Li, Jose Caetano Villasboas, Aaron S. Mansfield, Roxana S. Dronca, Haidong Dong

ONCOIMMUNOLOGY (2020)

Meeting Abstract Rheumatology

Overall Survival in Patients with PD-1 Inhibitor-related Inflammatory Arthritis and Metastatic Melanoma

Michael Richter, Jacob Orme, Heidi Finnes, Uma Thanarajasingam

ARTHRITIS & RHEUMATOLOGY (2019)

Meeting Abstract Oncology

Expression of tumor matrix metalloproteases ADAM10 and ADAM17 correlates with low PD-L1 protein-to-mRNA ratio in multiple tumors, predicting poor outcomes

Aaron Mansfield, Jacob Orme, Roxana Dronca, Haidong Dong

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Meeting Abstract Hematology

Disparities in Outcomes of Patients with Multiple Myeloma Based on Geographic Distance from NCI-Designated Cancer Centers: A SEER Based Analysis

Jacob Orme, Ronald S. Go, Shaji K. Kumar, Angela Dispenzieri, Morie A. Gertz, Francis K. Buadi, David Dingli, Nelson Leung, Martha Q. Lacy, Prashant Kapoor, John A. Lust, Yi Lin, Stephen J. Russell, Suzanne R. Hayman, Steven Zeldenrust, Taxiarchis Kourelis, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar, Wilson I. Gonsalves

Letter Medicine, General & Internal

Axillary Mass and Hypercalcemia: The Value of a Physical Examination

Jacob Orme, Diana Purushotham

AMERICAN JOURNAL OF MEDICINE (2017)

Article Medicine, Research & Experimental

Macrophage Subpopulations in Systemic Lupus Erythematosus

Jacob Orme, Chandra Mohan

DISCOVERY MEDICINE (2012)

Article Rheumatology

A Genopedia of Lupus Genes - Lessons from Gene Knockouts

Yuyuan Guo, Jacob Orme, Chandra Mohan

CURRENT RHEUMATOLOGY REVIEWS (2013)

暂无数据